Genzyme Centre Beijing – R&D Center
RMJM Hillier, the North American division of U.K.-based RMJM Group, announces that the firm has been selected as design architect and laboratory planner for a 200,000-sqft, $90m research and development center in Beijing for Genzyme Corp., one of the world’s leading biotechnology companies